UniProt ID | DNJB6_HUMAN | |
---|---|---|
UniProt AC | O75190 | |
Protein Name | DnaJ homolog subfamily B member 6 | |
Gene Name | DNAJB6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 326 | |
Subcellular Localization | Cytoplasm, perinuclear region . Nucleus . Cytoplasm, myofibril, sarcomere, Z line . | |
Protein Description | Plays an indispensable role in the organization of KRT8/KRT18 filaments. Acts as an endogenous molecular chaperone for neuronal proteins including huntingtin. Suppresses aggregation and toxicity of polyglutamine-containing, aggregation-prone proteins. Isoform B but not isoform A inhibits huntingtin aggregation. Has a stimulatory effect on the ATPase activity of HSP70 in a dose-dependent and time-dependent manner and hence acts as a co-chaperone of HSP70. Also reduces cellular toxicity and caspase-3 activity.. | |
Protein Sequence | MVDYYEVLGVQRHASPEDIKKAYRKLALKWHPDKNPENKEEAERKFKQVAEAYEVLSDAKKRDIYDKYGKEGLNGGGGGGSHFDSPFEFGFTFRNPDDVFREFFGGRDPFSFDFFEDPFEDFFGNRRGPRGSRSRGTGSFFSAFSGFPSFGSGFSSFDTGFTSFGSLGHGGLTSFSSTSFGGSGMGNFKSISTSTKMVNGRKITTKRIVENGQERVEVEEDGQLKSLTINGVADDDALAEERMRRGQNALPAQPAGLRPPKPPRPASLLRHAPHCLSEEEGEQDRPRAPGPWDPLASAAGLKEGGKRKKQKQREESKKKKSTKGNH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MVDYYEVLGVQ ----CCCHHHHHCCC | 7.07 | 27642862 | |
5 | Phosphorylation | ---MVDYYEVLGVQR ---CCCHHHHHCCCC | 8.63 | 29496907 | |
15 | Phosphorylation | LGVQRHASPEDIKKA HCCCCCCCHHHHHHH | 23.77 | 30576142 | |
18 | Ubiquitination | QRHASPEDIKKAYRK CCCCCHHHHHHHHHH | 62.48 | - | |
20 | Ubiquitination | HASPEDIKKAYRKLA CCCHHHHHHHHHHHH | 43.61 | - | |
20 | 2-Hydroxyisobutyrylation | HASPEDIKKAYRKLA CCCHHHHHHHHHHHH | 43.61 | - | |
20 (in isoform 2) | Ubiquitination | - | 43.61 | - | |
21 | Ubiquitination | ASPEDIKKAYRKLAL CCHHHHHHHHHHHHH | 51.49 | - | |
23 | Phosphorylation | PEDIKKAYRKLALKW HHHHHHHHHHHHHHC | 19.70 | 29496907 | |
29 | Ubiquitination | AYRKLALKWHPDKNP HHHHHHHHCCCCCCC | 37.54 | 21890473 | |
29 | Ubiquitination | AYRKLALKWHPDKNP HHHHHHHHCCCCCCC | 37.54 | 21890473 | |
29 (in isoform 2) | Ubiquitination | - | 37.54 | 21890473 | |
29 | Ubiquitination | AYRKLALKWHPDKNP HHHHHHHHCCCCCCC | 37.54 | 21890473 | |
29 (in isoform 3) | Ubiquitination | - | 37.54 | 21890473 | |
29 (in isoform 1) | Ubiquitination | - | 37.54 | 21890473 | |
34 | Ubiquitination | ALKWHPDKNPENKEE HHHCCCCCCCCCHHH | 78.01 | - | |
34 (in isoform 2) | Ubiquitination | - | 78.01 | - | |
39 | Ubiquitination | PDKNPENKEEAERKF CCCCCCCHHHHHHHH | 56.10 | - | |
39 (in isoform 2) | Ubiquitination | - | 56.10 | - | |
47 | Ubiquitination | EEAERKFKQVAEAYE HHHHHHHHHHHHHHH | 47.07 | - | |
47 (in isoform 2) | Ubiquitination | - | 47.07 | - | |
53 | Phosphorylation | FKQVAEAYEVLSDAK HHHHHHHHHHHHHHH | 9.70 | 20090780 | |
57 | Phosphorylation | AEAYEVLSDAKKRDI HHHHHHHHHHHHCCH | 40.47 | - | |
60 (in isoform 1) | Ubiquitination | - | 54.02 | 21890473 | |
60 (in isoform 3) | Ubiquitination | - | 54.02 | 21890473 | |
60 (in isoform 2) | Ubiquitination | - | 54.02 | 21890473 | |
60 | Ubiquitination | YEVLSDAKKRDIYDK HHHHHHHHHCCHHHH | 54.02 | 21906983 | |
60 | Ubiquitination | YEVLSDAKKRDIYDK HHHHHHHHHCCHHHH | 54.02 | 21890473 | |
61 | Ubiquitination | EVLSDAKKRDIYDKY HHHHHHHHCCHHHHH | 57.96 | - | |
65 | Phosphorylation | DAKKRDIYDKYGKEG HHHHCCHHHHHCCCC | 15.63 | 29496907 | |
67 (in isoform 2) | Ubiquitination | - | 38.64 | 21890473 | |
67 | Ubiquitination | KKRDIYDKYGKEGLN HHCCHHHHHCCCCCC | 38.64 | 21890473 | |
67 | Ubiquitination | KKRDIYDKYGKEGLN HHCCHHHHHCCCCCC | 38.64 | 21890473 | |
67 | Ubiquitination | KKRDIYDKYGKEGLN HHCCHHHHHCCCCCC | 38.64 | 21890473 | |
67 (in isoform 1) | Ubiquitination | - | 38.64 | 21890473 | |
67 (in isoform 3) | Ubiquitination | - | 38.64 | 21890473 | |
68 | Phosphorylation | KRDIYDKYGKEGLNG HCCHHHHHCCCCCCC | 30.45 | 29496907 | |
70 | Ubiquitination | DIYDKYGKEGLNGGG CHHHHHCCCCCCCCC | 45.58 | - | |
70 (in isoform 2) | Ubiquitination | - | 45.58 | - | |
81 | Phosphorylation | NGGGGGGSHFDSPFE CCCCCCCCCCCCCCC | 25.02 | 30622161 | |
85 | Phosphorylation | GGGSHFDSPFEFGFT CCCCCCCCCCCCCEE | 30.46 | 30622161 | |
132 | Phosphorylation | NRRGPRGSRSRGTGS CCCCCCCCCCCCCCC | 28.50 | 20068231 | |
134 | Phosphorylation | RGPRGSRSRGTGSFF CCCCCCCCCCCCCCH | 36.44 | 20068231 | |
135 | Methylation | GPRGSRSRGTGSFFS CCCCCCCCCCCCCHH | 45.65 | - | |
147 | Ubiquitination | FFSAFSGFPSFGSGF CHHHHCCCCCCCCCC | 4.42 | - | |
176 | Ubiquitination | HGGLTSFSSTSFGGS CCCCCCCCCCCCCCC | 32.26 | - | |
190 | Phosphorylation | SGMGNFKSISTSTKM CCCCCCCEEECCCCE | 20.03 | 22210691 | |
196 (in isoform 3) | Ubiquitination | - | 40.39 | 21890473 | |
196 (in isoform 1) | Ubiquitination | - | 40.39 | 21890473 | |
196 | Acetylation | KSISTSTKMVNGRKI CEEECCCCEECCEEE | 40.39 | 25953088 | |
196 | Ubiquitination | KSISTSTKMVNGRKI CEEECCCCEECCEEE | 40.39 | 21890473 | |
196 | Ubiquitination | KSISTSTKMVNGRKI CEEECCCCEECCEEE | 40.39 | 21890473 | |
196 (in isoform 2) | Ubiquitination | - | 40.39 | 21890473 | |
196 | Ubiquitination | KSISTSTKMVNGRKI CEEECCCCEECCEEE | 40.39 | 21890473 | |
225 (in isoform 2) | Ubiquitination | - | 35.22 | 21890473 | |
225 | Ubiquitination | VEEDGQLKSLTINGV EECCCCEEEEEECCC | 35.22 | - | |
226 | Phosphorylation | EEDGQLKSLTINGVA ECCCCEEEEEECCCC | 39.06 | - | |
228 | Phosphorylation | DGQLKSLTINGVADD CCCEEEEEECCCCCC | 21.35 | 28555341 | |
232 (in isoform 2) | Ubiquitination | - | 4.58 | 21890473 | |
253 | Ubiquitination | GQNALPAQPAGLRPP CCCCCCCCCCCCCCC | 26.83 | - | |
257 | Ubiquitination | LPAQPAGLRPPKPPR CCCCCCCCCCCCCCC | 8.91 | - | |
267 | Phosphorylation | PKPPRPASLLRHAPH CCCCCCHHHHHHCCC | 30.53 | 21406692 | |
277 | Phosphorylation | RHAPHCLSEEEGEQD HHCCCCCCCCCCCCC | 48.64 | 29255136 | |
297 | Phosphorylation | GPWDPLASAAGLKEG CCCCHHHHHHCHHHH | 26.74 | 30622161 | |
302 | Ubiquitination | LASAAGLKEGGKRKK HHHHHCHHHHHHHHH | 54.09 | 2190698 | |
302 | Acetylation | LASAAGLKEGGKRKK HHHHHCHHHHHHHHH | 54.09 | 25953088 | |
302 (in isoform 1) | Ubiquitination | - | 54.09 | 21890473 | |
306 | Ubiquitination | AGLKEGGKRKKQKQR HCHHHHHHHHHHHHH | 72.41 | - | |
306 | Acetylation | AGLKEGGKRKKQKQR HCHHHHHHHHHHHHH | 72.41 | 25953088 | |
312 (in isoform 3) | Phosphorylation | - | 56.37 | 25849741 | |
314 (in isoform 3) | Phosphorylation | - | 65.22 | 25850435 | |
315 (in isoform 3) | Phosphorylation | - | 70.78 | 25849741 | |
316 | Phosphorylation | KQKQREESKKKKSTK HHHHHHHHHHHHCCC | 45.05 | - | |
321 | Phosphorylation | EESKKKKSTKGNH-- HHHHHHHCCCCCC-- | 44.20 | 26670566 | |
322 | Phosphorylation | ESKKKKSTKGNH--- HHHHHHCCCCCC--- | 52.42 | 26670566 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DNJB6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNJB6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJB6_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
K1C18_HUMAN | KRT18 | physical | 10954706 | |
HDAC4_HUMAN | HDAC4 | physical | 20159555 | |
HDAC6_HUMAN | HDAC6 | physical | 20159555 | |
SIR2_HUMAN | SIRT2 | physical | 20159555 | |
HDAC4_HUMAN | HDAC4 | physical | 18163532 | |
ALKB1_HUMAN | ALKBH1 | physical | 18163532 | |
A4_HUMAN | APP | physical | 21832049 | |
DNJB2_HUMAN | DNAJB2 | physical | 26186194 | |
CL045_HUMAN | C12orf45 | physical | 26186194 | |
BAG3_HUMAN | BAG3 | physical | 22366786 | |
HSPB8_HUMAN | HSPB8 | physical | 22366786 | |
CHIP_HUMAN | STUB1 | physical | 22366786 | |
HSPB8_RAT | Hspb8 | physical | 22366786 | |
CL045_HUMAN | C12orf45 | physical | 28514442 | |
DNJB2_HUMAN | DNAJB2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
603511 | Limb-girdle muscular dystrophy 1E (LGMD1E) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND MASSSPECTROMETRY. |